Ten healthy unpremedicated male volunteers were exposed to an average inspired concentration of 3.6% desflurane 
The new inhalation anaesthetic, desflurane (I-653), is a methyl ethyl ether halogenated only with fluorine. It has a molecular weight of 168 Da, a boiling point of 23.5 °C and a vapour pressure of 644.3 mm Hg at 20 °C. Its stability appears to equal or exceed that of all potent inhaled agents in clinical use [1] [2] [3] . Results of studies in rats suggest that it is free from hepatic and renal toxicity [4, 5] . Serum or urinary inorganic and organic fluoride concentrations do not increase significantly, or increases only slightly, in enzyme-induced rats after exposure to desflurane for 2 h at 1.6 MAC [3] , and in swine after exposure at 5.5 MAC-h there was no detectable increase in serum concentration of fluoride immediately after anaesthesia and a 17% increase after 4h; this compares with a three-fold increase at comparable times following 5.5 MAC-h exposure to isoflurane [6] .
We investigated hepatic and renal function and standard haematological and biochemical indices after exposure of healthy male volunteers to desflurane. We also measured biotransformation as defined by changes in concentrations of serum and urinary inorganic fluoride and total urinary organic fluoride.
SUBJECTS AND METHODS
Eleven healthy male volunteers were studied after obtaining institutional Ethics Committee approval and written informed consent. The first four volunteers were department members (who had not worked in an operating theatre environment for at least 3 days before exposure to desflurane) and most of the remainder were medical students. No volunteer had been anaesthetized in the previous 12 months, none had smoked for at least 5 yr and none had taken any medications for at least 2 weeks before the study. We excluded volunteers who had a history of significant disease, a positive Australia antigen result, or an illicit drug history. A full physical examination was performed. Urine microscopy, fundoscopy, oral temperature, electrocardiography and standard haematological and biochemical tests were undertaken also (tables I, II). Before exposure to desflurane, volunteers abstained from alcohol and caffeine-containing drinks for 48 h and all were admitted to Guy's Hospital on the afternoon before study. Department members were kept in hospital overnight after the study and all other volunteers were kept in the Clinical Research Unit until completion of all investigations (7 days). Thus collection of all specimens, including 24-h urine samples, could be guaranteed.
Volunteers were unpremedicated and exposed only to desflurane in oxygen. Before exposure to desflurane an i.v. infusion of Hartmann's solution 3 ml kg" 1 h" 1 was started and continued throughout the study until the subject was taking oral fluids freely. A sampling cannula was sited in the arm opposite to that used for the infusion. We exposed the first volunteer (one of the investi- gators, J.N.C.), to subanaesthetic concentrations of the agent for approximately 1 h and demonstrated lack of toxicity at this concentration before exposing the remaining volunteers to anaesthetic concentrations of the agent. Immediately before exposure to desflurane, volunteers emptied their bladders. The agent was breathed via a clear plastic cuffed mask attached by a corrugated Teflon tube to an anaesthetic breathing system containing soda-lime for absorption of carbon dioxide. Inspired and expired desflurane concentrations were measured by Datex Multigas analysers, modified to measure desflurane, which were calibrated before and after each study with gravimetrically prepared gases containing 1.5, 3.0 and 6.0% desflurane. The anaesthetic was delivered by a modified Ohio DM 5000 anaesthetic machine with an electrically heated, temperature controlled vaporizer (direct metering vaporization). During the study period subjects were monitored using a 12-lead ECG, frequent (at least 5-min intervals) arterial pressure measurement and pulse oximetry. The first six subjects were exposed initially to 1.8% inspired desflurane for 30 min and the second five subjects were exposed initially to 5.4% inspired agent for the same period of time. In all subjects the inspired concentration was increased until there was no response to a standard painful stimulus (tetanic stimulation of the ulnar nerve for 30 s using a supramaximal stimulus)-that is, until they were anaesthetized.
Assessment of liver function
Serum concentrations of total and unconjugated (indirect) bilirubin were measured before (control) and immediately after exposure to desflurane (0 h) and at 4, 24, 72 and 192 h after exposure. Concentrations of the following liver enzymes in serum were measured also at these times: aspartate amino transferase (AST) and alanine amino transferase (ALT) (these are known also by the products of the reaction rather than by the aminogroup donor as glutamic and oxalo-acetic, and glutamic and pyruvic transaminase (SGOT and SGPT, respectively); alkaline phosphatase, which catalyses the release of inorganic phosphate from a phosphate ester substrate; y-glutamyl transpeptidase, which is an enzyme that is increases in circumstances which induce liver microsomal enzymes (e.g. consumption of alcohol).
Assessment of renal function
Urine was examined microscopically for leucocytes, red blood cells, casts and crystals at die screening visit and 4, 24, 72 and 192 h after anaesthesia. To determine creatinine clearance, urine and plasma concentrations of creatinine were measured together widi urine volume. This was done before exposure to desflurane and 24 and 72 h after exposure. Urine concentrating ability was determined also at these times. Two other tests of renal function were performed before exposure (control) and 4 and 24 h after exposure: measurement of urinary retinol-binding protein and P-N-acetyl-D-glucosaminidase-each a sensitive indicator of drug-induced renal damage. Retinol-binding protein (RBP) is a low molecular weight (21000 Da) protein bound largely to prealbumin. The unbound fraction is filtered at the glomerulus and then reabsorbed totally in the proximal convoluted tubule. Excretion of this low molecular weight protein indicates impairment of tubular function. P-N-acetyl-D-glucosaminidase (NAG) is a lysosomal enzyme with a molecular weight of 150 000 Da. Its size precludes filtration through the normal glomerulus. This enzyme exists in high concentration in renal tubules and increased NAG activity in urine indicates leakage of lysosomal enzymes and nephrotoxic damage.
Serum and urine inorganic fluoride and urinary non-volatile organic fluoride
Serum was analysed for inorganic fluoride before (control) and at 1, 4, 24, 72 and 192 h after anaesthesia. Urinary concentration and excretion rate of organic and inorganic fluoride were determined before (control) and 24, 48 and 72 h following anaesthesia, by the method of Fry and Taves [7] . Briefly, thawed serum and urine samples were centrifuged at 10000 £ for 3 min to remove paniculate matter. Twenty microlitre of sodium acetate buffer 5 mol litre" 1 (pH 4
fluoride standards on a logarithmic scale. Sodium calibration curves were obtained with the use of distilled water or in the presence of control serum or urine. The urine was analysed also for non-volatile organic fluoride by die sodium fusion method of Stoltis and Gandolfi [8] . Organic fluoride from urine samples was calculated by subtracting the free fluoride ion in the original sample from the total fluoride content determined by the sodium fusion technique, after correction for the efficiency of organic fluoride detection in urine (90.4 ±18.3%; n = 25).
All data are reported as mean (SD). Measured data were analysed by one-way analysis of variance and paired t test with a Bonferroni correction as applicable.
RESULTS
The first volunteer was exposed to an appreciably lower (1.8% inspired) concentration of the agent for a shorter period (1 h) than the other volunteers and thus the data from this subject (which were unremarkable) were not included with those of the remaining 10 subjects. The latter were exposed to desflurane for 89 (17) min at an average concentration of 3.6% inspired (range 1.8-6.2%). Haematological and biochemical tests before and after exposure were unremarkable and, with the exceptions detailed below, any small changes after anaesthesia could be explained in terms of the period of fasting which participation in the study entailed.
The white blood cell count increased significantly (P < 0.01) immediately after exposure from 5.9 (1.3) x 10" litre-1 to 8.3 (1.1) x 10 9 litre" 1 , 1.2) 4.8(1.2) 4.7(1.0) 4.7(1.2 1 at 4, 24, 72 and 192 h, respectively, after exposure. Both subjects were young men engaged in athletic activities and, because they had no other abnormal data, we concluded that these increased values represented increases which are seen after muscular activity. In isolation, the data did not warrant excluding the subjects from the study. Triglyceride values, both before and after the trial, were also slightly increased in some subjects on some occasions. Again, when occurring in isolation before the study, this was not considered sufficient to warrant exclusion of the subject from the trial.
TABLB III. Renal function tests (mean (SD)) (n = 10). RBP = Retinal binding protein; NAG = 0-Nacttyl-D-glucosaminidaie

Time after test drug (h)
Urinary microscopy did not reveal abnormalities at any time after exposure, and urinary concentrating ability was maintained at 24 and 72 h (sp.gr. 1015 control; 1020 at 24 h; 1020 at 72 h). Renal function tests were unchanged by exposure to desflurane (table III) . Liver function tests also were unchanged by exposure to desflurane (table IV) .
Serum and urinary fluoride ion and non-volatile urinary organic fluoride concentrations did not change (table V) . Urinary fluoride excretion rate increased significantly (P = 0.0057) for the first 24 h and the increase in organic fluoride excretion rate approached significance (P = 0.033). (7) 79 (12) 1.4(0.6) 6.4(1.9) 7.8(2.1)
DISCUSSION
The molecular structure of desflurane differs from that of isoflurane only in the substitution of fluorine for chlorine at the alpha ethyl carbon. It has a physical stability equal to or more than that of isoflurane in terms of their relative degradation in soda-lime of varying temperature and water content [1, 2] . This molecular stability suggests that desflurane undergoes minimal biotransformation. Indicators of the degree of biotransformation of fluorinated anaesthetics include the serum and urinary concentrations of fluoride ions and total urinary organic fluoride concentrations. Koblin and colleagues [3] have investigated the biotransformation of methoxyflurane, halothane, isoflurane and desflurane in rats pretreated with phenobarbitone in a series of controlled experiments. There were very marked (up to a 100-fold) increases in plasma and urinary fluoride ions and urinary organic fluoride concentrations in rats exposed to halothane and methoxyflurane, whereas isoflurane caused a measurable but smaller increase. The concentrations of fluoride after desflurane were virtually indistinguishable from those of the control animals. Similarly, in swine exposed to approximately 5.5 MAC-h of isoflurane or desflurane, plasma concentrations of fluoride ion were three times greater than control values immediately after and at 4 h after exposure to isoflurane, whereas there was no detectable increase immediately after anaesthesia with desflurane and only a 17 % increase after 4 h [6] . The foregoing animal data suggest that desflurane is biotransformed significantly less than all existing halogenated anaesthetic agents. Our data indicate that, at the exposures in this study, desflurane was also minimally biotransformed in man. Volunteers were exposed to no other drug and received desflurane at concentrations up to 6 % for approximately 90 min, the average inspired concentration being 3.6%. The data concerning the potency of desflurane in dogs, rabbits and rats, together with previous studies of comparative potency, suggest that the projected human MAC is about 5.1% [9] . Thus the volunteers were exposed to approximately 1 MAC-h of desflurane. This exposure produced no measurable increase in serum fluoride ions, urinary fluoride ions and total urinary concentration of organic fluoride. There was a slight, but measurable, increase in excretion rate of urinary fluoride ion. However, this was related probably to the relative diuresis which occurred after allowing volunteers to drink freely after exposure to desflurane which had been preceeded by a 15-h fast.
Various studies have examined the potential of desflurane to cause toxicity in animals. Eger, Johnson and Ferrell [4] subjected rats to six, 2-h exposures of 1.6 MAC isoflurane or desflurane in a controlled study and reported that no tissue damage attributable to the anaesthetics occurred and weight gain was not affected. This lack of toxicity extended to an enzyme-induced hypoxic rat model [5] . The animals were pre-treated with phenobarbitone and exposed for 1 h to 12% oxygen and no anaesthesia (control) or to 1.2 MAC halothane, isoflurane or desflurane. Liver, kidney and lung specimens were examined 24 h after exposure. Pulmonary and renal damage was not evident in any of the groups, but the livers of all rats exposed to halothane had marked swelling and centxilobular necrosis, whereas isoflurane produced only slight injury (20 % of rats had minor swelling and centrilobular necrosis) and no damage was discernible in the control or desflurane groups.
Administration of 1 MAC-h of desflurane did not alter any indices of liver or renal function in our volunteers. In addition to the standard tests of liver and renal function, we used two recently developed and very specific indices of renal integrity, namely measurement of urinary RBP and NAG. Increased excretion of NAG is a particularly sensitive index of drug-induced nephrotoxicity [10, 11] and the presence of RBP in urine is considered to be the most specific marker yet developed for tubular damage of any cause [12] . Exposure to desflurane caused no change in the excretion of these proteins. Although we could discern no evidence of hepatic or renal damage, it must be emphasized that our study was limited to an approximately 1 MAC-h exposure in healthy young male volunteers. Although these results in man are consistent with those from animals, a more definite conclusion on the safety of desflurane must await exposure to higher concentrations of the anaesthetic and to larger numbers of subjects, particularly patients with disease states and drug histories.
